Search
Now showing items 21-24 of 24
Antimicrobials as single and combination therapy for colistin-resistant pseudomonas aeruginosa at a university hospital in Thailand
Global infections with colistin-resistant Pseudomonas aeruginosa (CoR-PA) are increasing; there are currently very few studies focused on the antimicrobial susceptibility of CoR-PA isolates, and none from Thailand. Here, ...
Does vancomycin resistance increase mortality? clinical outcomes and predictive factors for mortality in patients with enterococcus faecium infections
The prevalence of enterococcal infection, especially E. faecium, is increasing, and the issue of the impact of vancomycin resistance on clinical outcomes is controversial. This study aimed to investigate the clinical ...
Optimizing doses of ceftolozane/tazobactam as monotherapy or in combination with amikacin to treat carbapenem-resistant pseudomonas aeruginosa
Carbapenem-resistant Pseudomonas aeruginosa (CRPA) is a hospital-acquired pathogen with a high mortality rate and limited treatment options. We investigated the activity of ceftolozane/tazobactam (C/T) and its synergistic ...
Treatment outcomes and risk factors related to mortality and treatment failure of patients infected with acinetobacter baumannii at a general hospital
OBJECTIVES: This retrospective study aimed to explore clinical outcomes and risk factors associated with mortality and treatment failure among A. baumannii infected patients.
MATERIAL AND METHODS: This retrospective ...